logo

For the Inventor, By the Inventor

Monroe, NY, United States of America

Gloria Jean Macewan

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Wyeth Holdings Corporation. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gloria Jean Macewan. Retrieved from https://idiyas.com/inventor/gloria-jean-macewan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 113 
 
Wyeth Holdings Corporation
 patents

Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6784184 - 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase (2004-08-31),
2. 6605628 - Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase (2003-08-12),

Title: Gloria Jean Macewan: Innovator in Cancer Therapy

Introduction

Gloria Jean Macewan is a notable inventor based in Monroe, NY (US). She has made significant contributions to the field of cancer therapy through her innovative inventions. With a total of 2 patents, Macewan's work focuses on developing novel compounds that can aid in the treatment of various cancers.

Latest Patents

Macewan's latest patents include methods involving 5-(arylsulfonyl)-, 5-(arylsulfinyl)-, and 5-(arylsulfanyl)-thiazolidine-2,4-diones. These compounds are designed to inhibit farnesyl-protein transferase, which plays a crucial role in the development of ras-oncogene-dependent tumors. Her inventions may serve as alternatives or complementary treatments to traditional cancer therapies for cancers affecting the pancreas, colon, bladder, and thyroid.

Career Highlights

Gloria Jean Macewan has been associated with Wyeth Holdings Corporation, where she has contributed her expertise in pharmaceutical research and development. Her work has been instrumental in advancing therapeutic options for patients suffering from cancer.

Collaborations

Macewan has collaborated with notable colleagues such as Joseph William Epstein and Semiramis Ayral-Kaloustian. These partnerships have further enhanced her research and development efforts in the field of oncology.

Conclusion

Gloria Jean Macewan's innovative work in cancer therapy exemplifies her commitment to improving treatment options for patients. Her patents reflect a significant advancement in the fight against cancer, showcasing her role as a leading inventor in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…